ArticleClinical and molecular hepatology2013

Lamivudine plus adefovir combination therapy for lamivudine resistance in hepatitis-B-related hepatocellular carcinoma patients.

Jeong Han Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.